Freeline Therapeutics is Drug Discovery in United Kingdom that focus on Therapeutics Holdings PLC business. Founded in 2015. They cover business area such as Freeline Therapeutics Holdings PLC, transformative adeno-associate virus, (AAV) vector-mediate gene therapy, patient, inherit systemic debilitate disease, its lead product candidate, hemophilia B, Fabry disease.
2015
( 9 years old in 2024 )
Therapeutics Holdings PLC
-
Stevenage Bioscience Catalyst
Gunnels Wood Road, Herts
Stevenage SG1 2FX
England, United Kingdom
Private
Freeline Therapeutics Holdings PLCtransformative adeno-associate virus(AAV) vector-mediate gene therapypatientinherit systemic debilitate diseaseits lead product candidatehemophilia BFabry disease
* We use standard office opening hours in near Freeline Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Freeline Therapeutics is Drug Discovery business from United Kingdom that founded in 2015 (9 years old in 2024), Freeline Therapeutics business is focusing on Therapeutics Holdings PLC.
Freeline Therapeutics headquarter office and corporate office address is located in Stevenage Bioscience Catalyst Gunnels Wood Road, Herts Stevenage SG1 2FX England, United Kingdom.
Freeline Therapeutics was founded in United Kingdom.
In 2024, Freeline Therapeutics is currently focus on Therapeutics Holdings PLC sector.
Above is snippet of Google Trends for "Therapeutics Holdings PLC" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Freeline Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
